Timed sequential therapy of the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomas
Matthias Holdhoff, Xiaobu Ye, Jeffrey G. Supko, Louis B. Nabors, Arati S. Desai, Tobias Walbert, Glenn J. Lesser, William L. Read, Frank S. Lieberman, Martin A. Lodge, Jeffrey Leal, Joy D. Fisher, Serena Desideri, Stuart A. Grossman, Richard L. Wahl, David Schiff
Dive into the research topics of 'Timed sequential therapy of the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomas'. Together they form a unique fingerprint.